GlucoTrack (NASDAQ:GCTK) Trading 2.9% Higher – Here’s What Happened

Posted by Defense World Staff on Jan 22nd, 2026

GlucoTrack, Inc. (NASDAQ:GCTK – Get Free Report) shares traded up 2.9% during trading on Wednesday . The company traded as high as $4.20 and last traded at $3.91. 2,536,909 shares traded hands during mid-day trading, an increase of 8,894% from the average session volume of 28,208 shares. The stock had previously closed at $3.80.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of GlucoTrack in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of “Sell”.

View Our Latest Analysis on GCTK

GlucoTrack Price Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 1.53 and a quick ratio of 1.53. The company’s 50-day moving average price is $4.80 and its 200-day moving average price is $5.73. The company has a market cap of $3.56 million, a P/E ratio of -0.11 and a beta of 0.33.

Institutional Trading of GlucoTrack

A hedge fund recently raised its stake in GlucoTrack stock. Bank of America Corp DE grew its position in GlucoTrack, Inc. (NASDAQ:GCTK – Free Report) by 102,125.0% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,089 shares of the company’s stock after purchasing an additional 4,085 shares during the period. Bank of America Corp DE owned approximately 0.85% of GlucoTrack worth $25,000 at the end of the most recent quarter. Institutional investors own 10.92% of the company’s stock.

GlucoTrack Company Profile

(Get Free Report)

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.